Page last updated: 2024-08-23

fomesafen and Bone Loss, Perimenopausal

fomesafen has been researched along with Bone Loss, Perimenopausal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bahadir, C; Cidem, M; Ekmekçi, H; Karacan, I; Karamehmetoğlu, SS; Küçük, SH1
Barberis, F; Baroni, MC; Bolla, I; Delsignore, R; Gariboldi, LM; Passeri, M1

Trials

1 trial(s) available for fomesafen and Bone Loss, Perimenopausal

ArticleYear
Effects of osteocytes on vibration-induced reflex muscle activity in postmenopausal women.
    Turkish journal of medical sciences, 2014, Volume: 44, Issue:4

    Topics: Adaptor Proteins, Signal Transducing; Aged; Bone Density; Bone Morphogenetic Proteins; Double-Blind Method; Electromyography; Female; Genetic Markers; Humans; Middle Aged; Muscle, Skeletal; Osteocytes; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies; Reflex; Vibration

2014

Other Studies

1 other study(ies) available for fomesafen and Bone Loss, Perimenopausal

ArticleYear
[Long-term local tolerability to intranasally administered salmon calcitonin in post-menopausal osteoporosis].
    Minerva medica, 1992, Volume: 83, Issue:12

    Topics: Administration, Intranasal; Calcitonin; Female; Humans; Middle Aged; Olfactory Mucosa; Osteoporosis, Postmenopausal; Reflex; Smell; Time Factors

1992